EUVIMED · CrossrefJournal
Journal of Organoid and Bioscience
ISSN 3029-2271 · Scipolis Pte. Ltd
Latest articles
ISoOR Gains ILAC Stakeholder Status: Advancing Global Standards in Organoid Biobanking
NIH Shift Away from Animal-Only Research Signals a Major Opportunity for Organoids
United Kingdom Launches £75 Million National Roadmap to Phase Out Animal Testing by 2030: A Defining Moment for Human-Relevant Research
Genmab Acquires Merus for $8 Billion: The First Organoid-Discovered Clinical Asset Drives the Largest European Oncology Deal of 2025
Major Shift in U.S. Research Policy: CDC to End All Nonhuman Primate Experiments by 31 December 2025
Biomaterials in Organoid Research: Design Principles, Functional Regulation, and Clinical Translation
Development of Patient-Derived Organoids from NUT Carcinoma: A Robust and Fully Documented Culture System
Expert Consensus on Patient Derived Tumor Organoid Culture and Drug Sensitivity Testing
Industry News (Jul 2023 to Dec 2023)
Innovating the Future: ISoOR 2024 Annual Meeting Achieves Remarkable Success
Expert consensus on culture of patient derived tumor organoids and organoids based drug sensitivity testing
Assessing the Efficacy and Feasibility of Conditioned Medium as a Culture Reagent for Tumor Organoid Culture: A Comprehensive Evaluation
Using Mouse Kidney Organoid Model for Nephrotoxic Drug Screening
Analysis of the Killing Activity of Immune Cells with Tumor Organoids
Industry News(Jan 2024 to May 2024)
White Paper The Next Frontier Exploring Organoids and Organ-on-a-Chip
When Is a Brain Organoid Ready to Learn and Think?
Unlocking the Potential of Organoid Models in Ferroptosis: A Breakthrough in Cancer Research
Will Black Box Warning Affect Development of CAR-T Therapy
Synergizing Organoid and CRISPR Technologies: Pioneering a New Era in Biomedical Research
Potential Role of Herbal Remedies on Mesenchymal Stem Cells: An Overview of New Therapeutic Strategies for Osteoporosis
Establishment of Patient-Derived Organoid Model from Hydrothorax and Ascites
Perspective on Tumor Organoids in Drug Screening and Cancer Precision Medicine
EUVIMED